Puma Biotechnology (PBYI) EBITDA (2008 - 2026)
Puma Biotechnology (PBYI) EBITDA from Dec 31, 2008 to Mar 31, 2026. The TTM Puma Biotechnology (PBYI) EBITDA is $40M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Puma Biotechnology (PBYI) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -17.36% |
| 3 Years TTM | +0.95% |
| 5 Years TTM | +21.69% |
Annual EBITDA change of Puma Biotechnology (PBYI)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$1.24M | -102.57% |
| 2025 | $48M | +13.53% |
| 2024 | $42M | -3.78% |
| 2023 | $44M | +31.59% |
| 2022 | $34M | +166.35% |
| 2021 | $13M | -161.86% |
| 2020 | -$20M | -34.23% |
| 2019 | -$31M | -64.51% |
| 2018 | -$87M | -69.86% |
| 2017 | -$290M | +5.13% |
| 2016 | -$275M | +15.01% |
| 2015 | -$240M | +69.08% |
| 2014 | -$142M | +160.34% |
| 2013 | -$54M | -26.65% |
| 2012 | -$74M | +600.47% |
| 2011 | -$11M | +105800.00% |
| 2010 | -$10K | -50.00% |
| 2009 | -$20K | +100.00% |
| 2008 | -$10K | N/A |
Comparison Puma Biotechnology (PBYI) five years EBITDA CAGR with competitors
Puma Biotechnology (PBYI) five years EBITDA CAGR is 21.70%.